Last 14 July 2016, the European Comission adopted the final Commission Implementing Decision C(2016)4708 regarding, within the framework of article 35 of Directive 2001/82/CE of the European Parliament and Council, the marketing authorisations for all veterinary medicinal products containing “colistin” in combination with other antimicrobial substances to be administered orally.
According to this Decision, the comercialisation authorisations for these veterinary drugs (Annex I) must be withdrawn.
Annex I. Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 July 2016 to 31 July 2016.
Friday, 16 September 2016/ EC/ European Union.